Christopher Ching, MD, BA

University of Utah
Salt Lake City, UT, United States

Residency: University of Utah Health, Internal Medicine, 2020-2023
Medical School: University of Texas Health Science Center San Antonio, 2016-2020
Undergraduate: University of California, Berkeley, Molecular and Cell Biology, 2011-2013

Disclosure information not submitted.

Presentation(s):

• 0837: Providers’ Adoption of 2017 Guidelines on DMARD Use Perioperatively for Elective Total Hip and Knee Arthroplasty at a Single Academic Center

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time